Literature DB >> 2723074

Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits.

R W Mahley1, K H Weisgraber, M M Hussain, B Greenman, M Fisher, T Vogel, M Gorecki.   

Abstract

Plasma cholesterol levels in cholesterol-fed rabbits were markedly reduced by the intravenous infusion or bolus injection of recombinant human apo E or rabbit plasma apo E. Administration of 6-70 mg of apo E resulted in an approximately 20-40% acute reduction in plasma cholesterol levels within 2-3 h. Plasma cholesterol levels remained reduced for 4-8 h after the administration of apo E. Furthermore, the intravenous injection of apo E reduced the plasma cholesterol levels in Watanabe heritable hyperlipidemic rabbits. The addition of apo E to [14C]cholesterol-labeled canine thoracic duct lymph or [14C]cholesterol-labeled chylomicrons resulted in accelerated plasma clearance of these diet-induced lipoproteins in normal rabbits, with the uptake occurring primarily in the liver. This study suggests that the amount or availability of apo E in the plasma of cholesterol-fed rabbits may be rate limiting for the normal clearance of diet-induced remnant lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723074      PMCID: PMC303940          DOI: 10.1172/JCI114126

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

Review 1.  Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.

Authors:  M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

2.  Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia.

Authors:  J P Kane; G C Chen; R L Hamilton; D A Hardman; M J Malloy; R J Havel
Journal:  Arteriosclerosis       Date:  1983 Jan-Feb

3.  Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia.

Authors:  M Fainaru; R W Mahley; R L Hamilton; T L Innerarity
Journal:  J Lipid Res       Date:  1982-07       Impact factor: 5.922

4.  Chylomicron metabolism during dietary-induced hypercholesterolemia in dogs.

Authors:  G W Melchior; R W Mahley; D K Buckhold
Journal:  J Lipid Res       Date:  1981-05       Impact factor: 5.922

5.  Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E.

Authors:  T Vogel; K H Weisgraber; M I Zeevi; H Ben-Artzi; A Z Levanon; S C Rall; T L Innerarity; D Y Hui; J M Taylor; D Kanner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake.

Authors:  M M Hussain; R W Mahley; J K Boyles; M Fainaru; W J Brecht; P A Lindquist
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

Review 7.  Plasma lipoproteins: apolipoprotein structure and function.

Authors:  R W Mahley; T L Innerarity; S C Rall; K H Weisgraber
Journal:  J Lipid Res       Date:  1984-12-01       Impact factor: 5.922

8.  Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. An animal model of human familial hypercholesterolemia.

Authors:  R J Havel; T Kita; L Kotite; J P Kane; R L Hamilton; J L Goldstein; M S Brown
Journal:  Arteriosclerosis       Date:  1982 Nov-Dec

9.  Radioimmunoassay of arginine-rich apolipoprotein of rat serum.

Authors:  M Fainaru; R J Havel; K Imaizumi
Journal:  Biochim Biophys Acta       Date:  1977-01-25

10.  Cholesteryl ester synthesis in macrophages: stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species.

Authors:  R W Mahley; T L Innerarity; M S Brown; Y K Ho; J L Goldstein
Journal:  J Lipid Res       Date:  1980-11       Impact factor: 5.922

View more
  25 in total

1.  Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.

Authors:  H Shimano; N Yamada; M Katsuki; K Yamamoto; T Gotoda; K Harada; M Shimada; Y Yazaki
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice.

Authors:  Shaila P Handattu; Geeta Datta; Richard M Epand; Raquel F Epand; Mayakonda N Palgunachari; Vinod K Mishra; Candyce E Monroe; Tamara D Keenum; Manjula Chaddha; G M Anantharamaiah; David W Garber
Journal:  J Lipid Res       Date:  2010-09-14       Impact factor: 5.922

Review 3.  Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family.

Authors:  Marco Dieckmann; Martin Frederik Dietrich; Joachim Herz
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

4.  Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.

Authors:  Gaurav Nayyar; David W Garber; Mayakonda N Palgunachari; Candyce E Monroe; Tamara D Keenum; Shaila P Handattu; Vinod K Mishra; G M Anantharamaiah
Journal:  Atherosclerosis       Date:  2012-06-23       Impact factor: 5.162

5.  Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.

Authors:  Gaurav Nayyar; Shaila P Handattu; Candyce E Monroe; Manjula Chaddha; Geeta Datta; Vinod K Mishra; Tamara D Keenum; Mayakonda N Palgunachari; David W Garber; G M Anantharamaiah
Journal:  Atherosclerosis       Date:  2010-10-27       Impact factor: 5.162

6.  Recognition of chylomicron remnants and beta-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver alpha 2-macroglobulin-recognition site.

Authors:  M C van Dijk; G J Ziere; W Boers; C Linthorst; M K Bijsterbosch; T J van Berkel
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

7.  Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing.

Authors:  Robert W Mahley; Yadong Huang
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

8.  Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice.

Authors:  H Shimano; Y Namba; J Ohsuga; M Kawamura; K Yamamoto; M Shimada; T Gotoda; K Harada; Y Yazaki; N Yamada
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

Authors:  S Bellosta; R W Mahley; D A Sanan; J Murata; D L Newland; J M Taylor; R E Pitas
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia.

Authors:  H Shimano; N Yamada; M Katsuki; M Shimada; T Gotoda; K Harada; T Murase; C Fukazawa; F Takaku; Y Yazaki
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.